相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis
Sabine Cepok et al.
ARCHIVES OF NEUROLOGY (2009)
Therapeutic targeting of chemokine signaling in Multiple Sclerosis
Isabel Hamann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system
Marcus Mueller et al.
JOURNAL OF IMMUNOLOGY (2007)
Interferon-β is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells
Mathias Buttmann et al.
JOURNAL OF VASCULAR RESEARCH (2007)
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
Adam Szczucinski et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Blockade of chemokine signaling in patients with multiple sclerosis
F. Zipp et al.
NEUROLOGY (2006)
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis
Diego Franciotta et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis
M. A. Moreira et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
M. Krakauer et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
MA Moreira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Subcutaneous Interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction
M Buttmann et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage
W Brück
JOURNAL OF NEUROLOGY (2005)
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
R Furlan et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Estrogen regulates CCR gene expression and function in T lymphocytes
R Mo et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulatory roles of sex hormones in cutaneous biology and immunology
N Kanda et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2005)
Clinical features and diagnosis of multiple sclerosis
FD Lublin
NEUROLOGIC CLINICS (2005)
Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis
A Elhofy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments
A Achiron et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease
H Bartosik-Psujek et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
R Bakshi et al.
NEUROLOGY (2004)
Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis
TL Sorensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Interferon-β induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis
M Buttmann et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis
RS Klein et al.
JOURNAL OF IMMUNOLOGY (2004)
Multiple sclerosis:: a study of chemokine receptors and regulatory T cells in relation to MRI variables
P Putheti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
Investigating chemokines and chemokine receptors in patients with multiple sclerosis - Opportunities and challenges
C Trebst et al.
ARCHIVES OF NEUROLOGY (2001)
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis
TL Sorensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis
MT Liu et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis
E Sindern et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
D Franciotta et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Chemokines as regulators of T cell differentiation
SA Luther et al.
NATURE IMMUNOLOGY (2001)
Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1a by interferon-beta
YCQ Zang et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
J Simpson et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
C Iarlori et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
分享论文
